The FDA has relaxed regulations on 21 different types of remote patient monitoring devices for the duration of the COVID-19 pandemic to protect healthcare workers from exposure to the virus.
In a new guidance released on Friday, the agency said it will not object to limited modifications to the indications, claims, functionality, or hardware or software the devices, listed here, as long as they do not impose undue risk.
The new guidance might make care for COVID-19 patients safer, as hospitals move patient monitoring equipment into hallways to reduce the need for providers to enter patient rooms.
Get the full story on our sister site, Medical Design & Outsourcing.